Tag Archive for: Conference

Weekly wrap-up: $100m Series B financing for a bivalent vaccine, to new clinical data from a cutting-edge antibody-drug conjugate…

/in

Vicebio Announces $100 Million Series B Financing and Initiation of Phase 1 Clinical Study of RSV/hMPV Bivalent Vaccine  Vicebio Ltd, a biopharmaceutical company developing novel vaccines against life-threatening respiratory viral infections, on Monday announced a $100 million Series B financing  led by TCGX  with investment from Goldman Sachs Alternatives, Avoro Ventures, venBio,  and participation from UniQuest and founding investor Medicxi.  London-based Vicebio said funding […]

Read more

The ‘must-attend’ Healthcare conferences Autumn / Winter 2024

/in

With the summer holidays drawing to a close, now is the time to be organising your conference calendar to maximise the opportunities these major events in life sciences present. Secure your travel and accommodation while prices are attractive, and availability is high.  As an official partner to many of the top events, Optimum is pleased […]

Read more

Gudrun Vogtentanz, Chief Scientific Officer at AMSilk, to speak at the Rethinking Materials Summit, 14 May 2024

/in

NEURIED, Germany, May 2, 2024 – AMSilk GmbH (“AMSilk”), a frontrunner in advanced biomaterials made from spider silk-based proteins, today announces that Gudrun Vogtentanz, Chief Scientific Officer, will participate in a panel discussion titled ‘Advancing the Bioeconomy: Plant-Based Specialty Chemicals and Bio-Based Building Block Molecules’ at the Rethinking Materials Summit in London on the 14th of May at 17:15. AMSilk’s […]

Read more

Xeltis Announces Latest Results from aXess Trials to be Presented at 46th Annual Charing Cross Symposium

/in

Two key presentations by leading KOLs highlight positive results from aXess trials in adult patients with end-stage renal disease who need vascular access to hemodialysis aXess is a restorative arteriovenous dialysis conduit which allows vascular access for hemodialysis through the creation of a new, long-term living vessel EINDHOVEN, The Netherlands, 17 April 2024 – Xeltis, […]

Read more

JPM ’24: The year’s healthcare barometer gives a more sunny outlook

/in

The JPM Healthcare Conference of 2024 may not have witnessed a mega-merger announcement, but there is anticipation that the M&A market could pick up this year, with predictions that the economic headwinds of recent years could turn into tailwinds.  The recent M&A Firepower report from EY, formerly known as Ernst & Young, has forecast a […]

Read more